Andrew Wilber, PhD, an SIU School of Medicine researcher and educator, studies how red blood cells produce hemoglobin and how gene-based therapies could improve treatment for inherited blood disorders such as sickle cell disease and β(beta)-thalassemia. His work aims to reduce or eliminate the need for lifelong blood transfusions while advancing more accessible therapies, reflecting SIU Medicine’s commitment to discovery, education and patient-focused innovation.